Linde plc (EU)

  • WKN: A2DSYC
  • ISIN: IE00BZ12WP82
  • Land: Irland

Nachricht vom 26.10.2021 | 10:15

Linde plc: Release of a capital market information

Linde plc / Disclosure of share buy-backs in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052: 38. Interim Report
26.10.2021 / 10:15
Dissemination of a Post-admission Duties announcement transmitted by DGAP - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.

Disclosure of share buy-backs in accordance with Article 5(1)(b) of Regulation (EU) No 596/2014 and Article 2(3) of Commission Delegated Regulation (EU) 2016/1052: 38. Interim Report
On January 25, 2021, the board of directors of Linde plc has authorized a share repurchase program for up to USD 5.0 billion of its ordinary shares. Under this program, Linde plc may acquire shares in the period from February 1, 2021 through July 31, 2023. Linde plc announced the terms of this program on the same date in accordance with Article 5(1)(a) of Regulation (EU) No 596/2014 and Article 2(1) of Commission Delegated Regulation (EU) 2016/1052.

In the period from 18.10.2021 through 22.10.2021, shares were repurchased under the program by brokers on markets in the United States and Germany (XETRA) as follows:

  United States Germany (XETRA) Total
Trading Date Aggregated Volume (shares) Weighted Average Price (USD)1 Aggregated Volume (shares) Weighted Average Price (EUR)1 Aggregated Volume (shares)
18.10.2021 20.000 307,3039 20.000 264,3634 40.000
19.10.2021 20.000 309,5162 20.000 264,6655 40.000
20.10.2021 20.000 311,3004 20.000 266,9115 40.000
21.10.2021 20.000 309,7553 20.000 266,2800 40.000
22.10.2021 20.000 313,8422 20.000 268,9374 40.000
 

1 Excluding costs incidental to the purchase.

Further details about the buy-back program and the above transactions (including venues) are available on the investor relations section of Linde plc's website (https://investors.linde.com/stock-and-dividend-information/2021-2023-share-buyback, short URL: https://t1p.de/sharebuyback3)

Guildford, United Kingdom, 26.10.2021

Linde plc



26.10.2021 The DGAP Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.
Archive at www.dgap.de



show this

GBC im Fokus

IGEA Pharma N.V. Realignment to CBD extraction

The goal is to become the quality and cost leader in the field of CBD in Europe. To this end, a GMP pharma compliant plant is being built in Switzerland. The supercritical CO2 extraction process is to be used to achieve the highest standard of quality. The CBD market is growing strongly and with the focus on quality leadership and pure extraction, IGEA Pharma's new business model should be able to occupy an attractive niche market. With the proprietary supercritical CO2-extraction technology, other markets such as vanilla, rose or rosemary can be developed in the medium term. Based on our DCF model, we have determined a fair value of € 1.05 (CHF 1.13) per share and assign a BUY rating.

Aktuelle Research-Studie

Original-Research: Gold Mountain Mining Corp. (von hanseatic stock publishing UG (haftungsbeschränkt)): Gold Mountain Mining Corp.

29. November 2021